GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » PanGenomic Health Inc (XCNQ:NARA) » Definitions » Forward PE Ratio

PanGenomic Health (XCNQ:NARA) Forward PE Ratio : 0.00 (As of May. 07, 2025)


View and export this data going back to 2022. Start your Free Trial

What is PanGenomic Health Forward PE Ratio?

PanGenomic Health's Forward PE Ratio for today is 0.00.

PanGenomic Health's PE Ratio without NRI for today is 0.00.

PanGenomic Health's PE Ratio (TTM) for today is 0.00.


PanGenomic Health Forward PE Ratio Historical Data

The historical data trend for PanGenomic Health's Forward PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PanGenomic Health Forward PE Ratio Chart

PanGenomic Health Annual Data
Trend
Forward PE Ratio

PanGenomic Health Quarterly Data
Forward PE Ratio

Competitive Comparison of PanGenomic Health's Forward PE Ratio

For the Health Information Services subindustry, PanGenomic Health's Forward PE Ratio, along with its competitors' market caps and Forward PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


PanGenomic Health's Forward PE Ratio Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, PanGenomic Health's Forward PE Ratio distribution charts can be found below:

* The bar in red indicates where PanGenomic Health's Forward PE Ratio falls into.


;
;

PanGenomic Health Forward PE Ratio Calculation

It's a measure of the price-to-earnings ratio (PE Ratio) using forecasted earnings for the calculation. While the earnings used are just an estimate and are not as reliable as current earnings data, there is still benefit in estimated P/E analysis. The forecasted earnings used in the formula can either be for the next 12 months or for the next full-year fiscal period.


PanGenomic Health  (XCNQ:NARA) Forward PE Ratio Explanation

The Forward PE Ratio of a company is often used to compare current earnings to estimated future earnings, as well as gaining a clearer picture of what earnings will look like without charges and other accounting adjustments. If earnings are expected to grow in the future, the Forward PE Ratio will be lower than the current PE Ratio. This measure is also used to compare one company to another with a forward-looking focus.

Trailing PE Ratio relies on what is already done. It uses the current share price and divides by the total EPS (Basic) over the past 12 months. PE Ratio can be affected by Non Operating Income such as the sale of part of businesses. This may increase for the current year or quarter dramatically. But it cannot be repeated over and over. Therefore PE Ratio without NRI is a more accurate indication of valuation than PE Ratio .


PanGenomic Health Forward PE Ratio Related Terms

Thank you for viewing the detailed overview of PanGenomic Health's Forward PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


PanGenomic Health Business Description

Traded in Other Exchanges
Address
3800 Wesbrook Mall, Suite 102, Vancouver, BC, CAN, V6S 2L9
PanGenomic Health Inc is a precision health company that has developed a self-care digital platform to deliver personalized, evidence-based information about natural treatments to support mental health. The company's mobile app, the Nara App, provides consumers with a knowledge base tailored to an individual's user profile, developed by tracking a user's treatment regimen and their specific genomic, proteomics, and microbiome data. The Company's mission is to promote and improve the health and wellness of people and society by providing a technology platform that identifies plant-based solutions tailored to the health profile of each individual.
Executives
Vincent Lum Director, Director or Senior Officer of Insider or Subsidiary (other than in 4,5,6), Senior Officer
Kaidong Zhang Senior Officer

PanGenomic Health Headlines

No Headlines